St. Joseph Hospital Health Center Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Syracuse New York United States (1869)

Organization Overview

First Clinical Trial
1974
NCT00000491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

asenapine (saphris) (1 trial)

Drugs in Phase 3 Trials (5)

acetylsalicylic acid (aspirin) (1 trial)

drotrecogin alfa, activated (Xigris) (1 trial)

fludrocortisone (florinef) (1 trial)

teriparatide (1 trial)

urea (1 trial)

Drugs in Phase 2 Trials (1)

cetuximab (erbitux) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Diseases, Metabolic (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cardiovascular Diseases (Phase 3)

Coronary Disease (Phase 3)

Heart Diseases (Phase 3)

Infarction (Phase 3)

Ischemia (Phase 3)

Lung Neoplasms (Phase 2)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Osteoporosis (Phase 3)

Psychomotor Agitation (Phase 4)

Shock (Phase 3)

Shock, Septic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7